Thursday, 24 Sep 2026
Empowering Chinese Pharma’s Global Expansion
Contact US
Home
About US
Policy Hub
Categories
Drug
Company
Deals
Policy / Regulatory
Medical Device
R&D
Legal / IP
Digital
Privacy Policy
Contact US
My News
Cancer
Clinical trial approval / initiation
Product approvals
Clinical trial results
Finance
ADC / XDC
Finanical Reports
Biotech
Market approval filings
PD-1/L1
Read History
Search
Pages
Home
Blog Index
POLICY HUB
Contact Us
Personalized
Read History
Categories
Company
Drug
Policy / Regulatory
Medical Device
R&D
Digital
Legal / IP
Deals
Have an existing account?
Sign In
Follow US
Fineline Cube
Follow:
14483
Articles
Company
Deals
Novartis Terminates TIGIT-Targeted Antibody Deal with BeiGene, Retains Rights to Ociperlimab
January 6, 2025
Company
Legal / IP
Biocytogen Pharmaceuticals Awarded CNIPA Patent for RenMab Human Antibody Mice Platform
December 2, 2024
Company
Deals
Guangdong’s OptoMedic Secures Over $27.8 Million in Pre-IPO Financing for Endoscopy Innovations
December 2, 2024
Company
Drug
Jiangsu Hengrui Pharmaceuticals’ Irinotecan and Bupivacaine Liposome Injections Get Clinical Trial Green Light in China
December 3, 2024
Company
Drug
Shanghai Junshi Biosciences’ Tuoyi Files for 9th Indication in China for RCC Treatment
December 2, 2024
Company
Drug
Jiangsu Hengrui Pharmaceuticals Receives Clinical Trial Approvals for Irinotecan and Bupivacaine Liposome Injections
December 3, 2024
Company
Drug
Shanghai Junshi Biosciences’ Tuoyi Files for 9th Indication in China for RCC Treatment
December 2, 2024
Company
Deals
Next Generation Gene Therapeutics Secures $40 Million in Series B Financing for Gene Therapy Development
December 2, 2024
Company
Deals
Ji Xing Pharmaceuticals and TSH Biopharm Announce Collaboration for Dry Eye Treatment in Taiwan
December 2, 2024
Company
Drug
Hrain Biotechnology’s Anti-CD70 T Cell Therapy HR010 Gets Tacit Approval for Renal Cancer Trial
December 2, 2024
Company
Drug
Huadong Medicine’s Elahere Receives Approval for FRα Positive Cancer Treatment in China
December 2, 2024
Company
Deals
WuXi Biologics Proposes Spin-Off and Listing of WuXi XDC on Hong Kong Stock Exchange
December 2, 2024
1
2
…
937
938
939
940
941
…
1,206
1,207
Welcome to Fineline Cube!
Username or Email Address
Password
Remember me
Lost your password?